US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

CNS/Neurology Market Research Reports & Industry Analysis

RSS Feeds

CNS/Neurology Industry Research & Market Reports

3  4  5  6    8    10  11  12  
Global and Chinese Ziprasidone Mesylate Industry, 2016 Market Research Report
1/20/2016 | published by: Prof-Research
... market. The report provides key statistics on the market status of the Ziprasidone Mesylate manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Firstly, the report provides ...  |  read more...
USD 2,900
Cerebral Infarction (Brain Infarction) Global Clinical Trials Review, H2, 2015
12/16/2015 | published by: GlobalData
... trials scenario. This report provides top line data relating to the clinical trials on Cerebral Infarction (Brain Infarction). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the ...  |  read more...
USD 2,500
Global Restless Legs Syndrome Industry 2015 Market Research Report
12/18/2015 | published by: 9Dimen Research
... Europe and Asia) and the main countries (United States, Germany, Japan and China). The report firstly introduced the Restless Legs Syndrome basics: definitions, classifications, applications and industry chain overview; industry policies and plans; product specifications; ...  |  read more...
USD 5,800
Global Neurodegenerative Diseases Drug Industry 2015 Market Research Report
12/18/2015 | published by: 9Dimen Research
... Europe and Asia) and the main countries (United States, Germany, Japan and China). The report firstly introduced the Neurodegenerative Diseases Drug basics: definitions, classifications, applications and industry chain overview; industry policies and plans; product specifications; ...  |  read more...
USD 5,800
Addiction - Pipeline Review, H2 2015
12/30/2015 | published by: Global Markets Direct
... Addiction, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Treatment Resistant Depression Global Clinical Trials Review, H2, 2015
12/23/2015 | published by: GlobalData
... report provides top line data relating to the clinical trials on Treatment Resistant Depression. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers ...  |  read more...
USD 2,500
Brain Hemorrhage Global Clinical Trials Review, H2, 2015
12/4/2015 | published by: GlobalData
... line data relating to the clinical trials on Brain Hemorrhage. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical ...  |  read more...
USD 2,500
Global Migraine Epidemiology and Patient Flow Analysis - 2016
12/16/2015 | published by: Fore Pharma
... report provides insights into Migraine epidemiology, Migraine diagnosed patients, and Migraine treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Migraine derived from epidemiological analysis, percentage of patients ...  |  read more...
USD 1,690
Global Depression Epidemiology and Patient Flow Analysis - 2016
12/16/2015 | published by: Fore Pharma
... report provides insights into Depression epidemiology, Depression diagnosed patients, and Depression treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Depression derived from epidemiological analysis, percentage of patients ...  |  read more...
USD 1,690
Neuromodulation Devices Global Market – Forecast To 2021
12/2/2015 | published by: IQ4I Research and Consultancy
... brings about life changing transformation in patients who fail to get better by traditional approaches. The opportunities to development new therapies for a wide variety of neurological and psychological conditions are attracting lot of companies, ...  |  read more...
USD 4,500
Schizophrenia Pipeline Highlights – 2016
12/16/2015 | published by: Fore Pharma
... clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing ...  |  read more...
USD 680
Glioblastoma Pipeline Highlights – 2016
12/16/2015 | published by: Fore Pharma
... clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing ...  |  read more...
USD 680
Traumatic Brain Injury Pipeline Highlights – 2016
12/16/2015 | published by: Fore Pharma
... emerging therapies for Traumatic Brain Injury in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating ...  |  read more...
USD 680
Attention Deficit Hyperactivity Disorder Pipeline Highlights – 2016
12/16/2015 | published by: Fore Pharma
... market. It covers emerging therapies for Attention Deficit Hyperactivity Disorder in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying ...  |  read more...
USD 680
Brain Cancer Pipeline Highlights – 2016
12/16/2015 | published by: Fore Pharma
... Brain Cancer in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and ...  |  read more...
USD 680
Autism Spectrum Disorder Pipeline Highlights – 2016
12/16/2015 | published by: Fore Pharma
... emerging therapies for Autism Spectrum Disorder in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating ...  |  read more...
USD 680
Brain Cancer - Pipeline Review, H2 2015
10/21/2015 | published by: Global Markets Direct
... therapeutic development for Brain Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Dementia - Pipeline Review, H2 2015
10/21/2015 | published by: Global Markets Direct
... Dementia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Global Brain Stroke Market Report: 2015 Edition
11/1/2015 | published by: Koncept Analytics
... blood vessels in the brain rupture (hemorrhagic). The vascular diseases affect normal functioning of the veins and arteries that constitute circulatory system of a human body generally in the form of blockage or rupture. The ...  |  read more...
USD 800
Nicotine Addiction - Pipeline Review, H2 2015
10/28/2015 | published by: Global Markets Direct
... therapeutic development for Nicotine Addiction, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Cerebral Infarction (Brain Infarction) - Pipeline Review, H2 2015
10/28/2015 | published by: Global Markets Direct
... report provides comprehensive information on the therapeutic development for Cerebral Infarction (Brain Infarction), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule ...  |  read more...
USD 2,000
Global Depression Drugs Market 2015-2019
6/10/2015 | published by: TechNavio - Infiniti Research Ltd.
... is characterized by sadness, loss of interest or pleasure, feelings of guilt or low self-worth, disturbed sleep or appetite, feelings of tiredness, and poor concentration. Depression can be roughly categorized into six different types. An ...  |  read more...
USD 3,000
Global Restless Legs Syndrome Market 2015-2019
6/10/2015 | published by: TechNavio - Infiniti Research Ltd.
... an unpleasant pain in the limbs, leading to a disturbance in sleep pattern of patients. The condition aggravates at night or when the person is at rest. It occurs in both genders, but higher prevalence ...  |  read more...
USD 2,500
Global Post-traumatic Stress Disorder Therapeutics Market 2015-2019
6/24/2015 | published by: TechNavio - Infiniti Research Ltd.
... DSM-IV codes found in the Diagnostic and Statistical Manual of Mental Disorders, published by the American Psychiatric Association (APA), PTSD is classified under anxiety disorders. PTSD can occur in individuals of any age, irrespective of ...  |  read more...
USD 2,500
Global Fibromyalgia Drugs Market 2015-2019
7/15/2015 | published by: TechNavio - Infiniti Research Ltd.
... the major symptoms. Unlike arthritis, it does not cause joint, muscle or other tissue inflammation. However, fibromyalgia is known to cause impairment of joints, soft tissues, and causes significant pain and fatigue. Fibromyalgia affects women ...  |  read more...
USD 2,500
3  4  5  6    8    10  11  12